| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―05 |
Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2 |
Yu. Yu. Polyakov, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, M. A. Mingalimov, S. A. Kardovskaya, et al. (+11) M. Ya. Smolyarchuk, T. N. Tolstykh, T. S. Chudnova, D. D. Ivanova, O. L. Kochneva, D. V. Lebedev, A. U. Abueva, A. M. Chistov, E. N. Zotina, I. V. Samsonova, M. A. Lysenko |
| 2 |
[GO] |
2024―Jan―17 |
Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19) |
E. N. Misyurina, E. A. Baryakh, N. F. Frolova, O. N. Kotenko, Z. Yu. Mutovina, S. S. Andreev, et al. (+18) T. N. Tolstykh, K. V. Yatskov, E. A. Karimova, A. B. Makeshova, O. A. Rukavitsyn, A. V. Misyurin, Yu. Yu. Polyakov, M. A. Mingalimov, T. S. Chudnova, D. E. Gagloeva, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets, E. I. Zhelnova |
| 3 |
[GO] |
2024―Jan―17 |
COVID-19 in patients with acute leukemia: 3 years' experience of pandemic |
T. S. Chudnova, E. N. Misyurina, E. A. Baryakh, T. N. Tolstykh, L. T. Shimanovskaya, D. E. Gagloeva, et al. (+10) E. I. Zhelnova, A. B. Makeshova, K. V. Yatskov, E. N. Zotina, D. D. Ivanova, M. A. Mingalimov, O. L. Kochneva, E. Yu. Grishina, Yu. Yu. Polyakov, V. N. Yakimets |
| 4 |
[GO] |
2024―Jan―17 |
Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic |
V. N. Yakimets, E. N. Misyurina, E. I. Zhelnova, E. A. Baryakh, K. V. Yatskov, A. B. Makeshova, et al. (+10) E. A. Karimova, E. N. Zotina, E. Yu. Grishina, D. E. Gagloeva, M. A. Mingalimov, T. N. Tolstykh, T. S. Chudnova, O. L. Kochneva, L. T. Shimanovskaya, Yu. Yu. Polyakov |
| 5 |
[GO] |
2024―Jan―17 |
Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic |
D. E. Gagloeva, E. N. Misyurina, T. N. Tolstykh, E. A. Baryakh, K. V. Yatskov, E. A. Karimova, et al. (+11) A. B. Makeshova, M. A. Mingalimov, T. S. Chudnova, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets, E. I. Zhelnova |
| 6 |
[GO] |
2024―Jan―17 |
Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors |
O. L. Kochneva, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, et al. (+12) Yu. Yu. Polyakov, A. B. Makeshova, M. A. Mingalimov, D. D. Ivanova, L. T. Shimanovskaya, E. N. Zotina, T. N. Tolstykh, E. Yu. Grishina, D. E. Gagloeva, V. N. Yakimets, A. I. Koneva, E. A. Karimova |
| 7 |
[GO] |
2024―Jan―17 |
Coronavirus infection after blood stem cell transplantation |
E. Yu. Grishina, E. N. Misyurina, E. I. Zhelnova, E. A. Baryakh, K. V. Yatskov, A. B. Makeshova, et al. (+10) E. A. Karimova, E. N. Zotina, D. E. Gagloeva, V. N. Yakimets, M. A. Mingalimov, T. N. Tolstykh, Yu. Yu. Polyakov, T. S. Chudnova, O. L. Kochneva, L. T. Shimanovskaya |
| 8 |
[GO] |
2024―Jan―17 |
Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group |
L. T. Shimanovskaya, E. N. Misyurina, E. A. Baryakh, E. I. Zhelnova, K. V. Yatskov, T. S. Chudnova, et al. (+11) A. B. Makeshova, M. A. Mingalimov, D. D. Ivanova, O. L. Kochneva, E. N. Zotina, T. N. Tolstykh, E. Yu. Grishina, D. E. Gagloeva, Yu. Yu. Polyakov, V. N. Yakimets, A. I. Koneva |
| 9 |
[GO] |
2024―Jan―17 |
Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study |
Yu. Yu. Polyakov, E. A. Baryakh, E. N. Misyurina, E. I. Zhelnova, K. V. Yatskov, A. B. Makeshova, et al. (+11) M. A. Mingalimov, T. N. Tolstykh, T. S. Chudnova, D. D. Ivanova, A. I. Koneva, O. L. Kochneva, E. N. Zotina, D. E. Gagloeva, E. Yu. Grishina, L. T. Shimanovskaya, V. N. Yakimets |
| 10 |
[GO] |
2023―Dec―09 |
Important issues of professional burnout among hematologists and hematology department nursing staff during the COVID-19 pandemic |
O. A. Aleshina, T. P. Nikitina, N. M. Porfirieva, D. E. Vybornykh, E. N. Parovichnikova, T. I. Ionova |
| 11 |
[GO] |
2023―May―31 |
Current opportunities to improve outcomes of COVID-19 infection prevention and course in patients with lymphoproliferative diseases (regional analysis) |
Ch. Kh. Valiakhmetova, E. I. Siraeva |
| 12 |
[GO] |
2022―Jul―20 |
COVID-19 infection in patients with chronic myeloid leukemia in the Orenburg region during the SARS-CoV-2 pandemic |
G. B. Kuchma, U. A. Yakubova, L. K. Kozlova, S. A. Lebedenko, F. R. Sayfutdinov |
| 13 |
[GO] |
2022―Jul―20 |
Immunochemotherapy of refractory classical Hodgkin's lymphoma with high-dose consolidation and autologous hematopoietic stem cell transplantation complicated by a new coronavirus infection |
L. S. Khayrullina, M. A. Vernyuk, A. M. Chervontseva, I. V. Cherkashina, E. E. Gushchina, A. A. Fedenko |
| 14 |
[GO] |
2022―Apr―14 |
Chemotherapy of hematological malignancies in patients with COVID-19 |
T. S. Chudnova, E. A. Baryakh, M. S. Litvinenko, T. N. Tolstykh, O. L. Kochneva, E. Y. Grishina, et al. (+5) E. N. Misyurina, K. V. Yatskov, E. I. Zhelnova, Y. Y. Polyakov, K. V. Kaluzhskaya |
| 15 |
[GO] |
2022―Apr―14 |
Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra |
K. A. Sychevskaya, S. K. Kravchenko |
| 16 |
[GO] |
2021―Jun―07 |
Vaccination against SARS-COV-2 in oncology |
A. A. Polyakov, V. V. Lunin, F. M. Abbaysbeyli, O. L. Timofeeva, V. B. Larionova, P. A. Zeynalova, A. A. Fedenko |
| 17 |
[GO] |
2020―Jul―18 |
Expert Council resolution on the specifics of multiple myeloma therapy during COVID-19 pandemic |
Article Editorial |
|
